Revisiting the pathogenesis of ovarian cancer: The central role of the fallopian tube

Archives of Gynecology and Obstetrics

Volumn 289, Issue 2, 2014, Pages 241-246

  Dietl, Johannes ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Fallopian tube; Ovarian cancer; Pathogenesis; Salpingectomy; STIC

Indexed keywords

CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL MIGRATION; DISEASE ASSOCIATION; DNA DAMAGE; EMBRYO DEVELOPMENT; ENDOMETRIUM CELL; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MOLECULAR GENETICS; NONHUMAN; OVARY CANCER; OVARY DEVELOPMENT; REVIEW; SALPINGECTOMY; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE TUBE; UTERINE TUBE CARCINOMA; ANIMAL; CANCER GRADING; CELL TRANSFORMATION; CYSTADENOCARCINOMA, SEROUS; EMBRYOLOGY; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; GENETICS; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PATHOLOGY; PHENOTYPE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; NEOPLASM GRADING; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PHENOTYPE; SALPINGECTOMY;

EID: 84896702756     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3041-3     Document Type: Review

References (42)

1. Dietl J, Marzusch K (1993) Ovarian surface epithelium and human ovarian cancer: a review. Gynecol Obstet Invest 35:129-135
2. Vaughan S, Coward JI, Bast RC et al (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11:719-725
3. Häusler S, Keller A, Chandran AP et al (2010) A new approach for ovarian cancer screening-characterization of miRNA profiles in peripheral blood. Br J Cancer 103:693-700
4. Seidman JD, Cho KR, Ronnett BM, Kurman RJ (2011) Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM (eds) Blaustein's pathology of the female genital tract, 6th edn. pp 679-784
5. le Shih M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511-1518
6. Blaustein A (1984) Peritoneal mesothelium and ovarian surface cells-shared characteristics. Int J Gynecol Pathol 3:361-375
7. Marquez RT, Baggerly KA, Patterson AP et al (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11:6116-6126
8. McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 oder BRCA2mutations: a case-control study. Lancet Oncol 8:26-34
9. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2:163
10. Johnson PA, Gilles JR (2013) The hen as a model of ovarian cancer. Nat Rev Cancer 13:432-436
11. Kuhn E, Kurman RJ, le Shih M (2012) Ovarian cancer is an imported disease: fact or fiction? Curr Obstet Gynecol Rep 1:1-9
12. Auersperg N (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30:12-21
13. Flesken-Nikitin A, Hwang C-I, Cheng C-Y et al (2013) Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche. Nature 495:241-245
14. Boyd C, McCluggage WG (2012) Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Am J Surg Pathol 36:368-375
15. Dubeau L (2008) The cell of origin of ovarian epithelial tumors. Lancet Oncol 9:1191-1197
16. Piek JM, van Diest PJ, Zweemer RP et al (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451-456
17. Przybycin CG, Kurman RJ, Ronnett BM et al (2010) Are all pelvic (non uterina) serous carcinomas of tubal origin? Am J Surg Pathol 34:1407-1416
18. Piek JM, Verheijen RM, Kenemans P et al (2003) BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol 90:491
19. Kindelberger DM, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161-169
20. Kuhn E, Kurman RJ, Vang R et al (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic highgrade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol 226:421-426
21. Fleming JS, Beaugie CR, Hariv I et al (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypothesis. Mol Cell Endocrinol 247:4-21
22. La Vecchia C (2006) Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 15:117-124
23. Murdoch WJ (2005) Carcinogenic potential of ovulatory genotoxicity. Biol Reprod 73:586-590
24. Veras E, Mao TL, Ayhan A et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behaviour: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844-853
25. Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363:1532-1543
26. Yamamoto S, Tsuda H, Takano M et al (2011) PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinomas. J Pathol 225:189-194
27. Hull ML, Escareno CR, Godsland JM et al (2008) Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 173:700-715
28. Sieh W, Salvador S, McGuire V et al (2013) Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol 42:579-589
29. Vang R, Shih le-M, Kurman RJ (2013) Fallopian tube precursors of ovarian low-and high-grade serous neplasms. Histopathology 62:44-58
30. Dietl J, Wischhusen J (2011) The forgotten fallopian tube. Nat Rev Cancer 11:227
31. Dietl J, Wischhusen J, Häusler FS (2011) The post-reproductive fallopian tube: better removed? Hum Reprod 26:2918-2924
32. Crum CP, McKeon FD, Xian W (2011) BRCA, the oviduct and the space and time continium of pelvic serous carcinogenesis. Int J Gynecol Cancer 22:S29-S34
33. Lorusso D, Di Rocco R, Mancini M, Raspagliesi F (2013) Highgrade serous tumor arising from fallopian tube in a BRCA mutation carrier after prophylactic oophorectomy. Case Rep Oncol 6:21-24
34. Greene MH, Mai PL, Schwartz PE (2011) Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 204:19e-1-6
35. Anderson CK, Wallace S, Guiahi M et al (2013) Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer 23:417-421
36. Kwon JS, Tinker A, Pansegrau G et al (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121:14-24
37. Parker WH, Broder MS, Chang E et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 113:1027-1037
38. Morelli M, Venturella R, Mocciaro R et al (2013) Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 129:448-451
39. Gao FF, Bhargara R, Yang H, et al. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum Pathol. 2013 (Epub ahead of print)
40. Westgren M (2012) Prevention of ovarian cancer-let's do something. AOGS 91:1009-1010
41. Erickson BK, Conner MG, Landon CN: The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 2013 (Epub ahead of print)
42. Collins JM, Domchek SM, Huntsman DG, Mitchell G (2011) The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol 12:1089-1091